Physician profile
Eric R Taylor
NPI 1487817235
$1,966.93
in general payments reported to CMS, 2019-2025
26 companies · $403 in 2025
The $403 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $232 · 2020: $195 · 2021: $147 · 2022: $392 · 2023: $245 · 2024: $354 · 2025: $403.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $916 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $916.31 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $306.84 | 2020-2024 | Provenge |
| Cook Medical LLC | $272.37 | 2019-2023 | Resonance |
| Astellas Pharma US INC | $215.19 | 2019-2025 | Xtandi |
| Abbvie INC. | $172.58 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $170.80 | 2023-2024 | Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $124.99 | 2020 | |
| Olympus America INC. | $90.02 | 2022-2025 | Itind System |
| Janssen Biotech, INC. | $84.99 | 2025 | Erleada |
| Boston Scientific Corporation | $66.90 | 2024-2025 | Lithovue, Ams 800 Artificial Urinary Sphincter |
| Tempus Ai, INC | $66.86 | 2024-2025 | Xt Cdx |
| Rochester Medical Corporation | $61.21 | 2022 | |
| Myovant Sciences INC. | $57.30 | 2022 | |
| Coloplast Corp | $46.80 | 2019-2022 | |
| Travere Therapeutics, INC. | $41.29 | 2019-2020 | |
| Medtronic, INC. | $25.15 | 2023 | Interstim |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $22.84 | 2025 | Adstiladrin |
| Urogen Pharma, INC. | $18.00 | 2021 | |
| Angiodynamics, INC. | $16.37 | 2022 | |
| Pfizer INC. | $15.83 | 2023 | |
| Dentsply Ih INC. | $14.86 | 2019 | |
| Cardinal Health 414 LLC | $13.47 | 2023 | |
| Telix Pharmaceuticals | $13.47 | 2023 | Illuccix |
| Antares Pharma, INC. | $12.72 | 2022 | |
| Neotract INC. | $12.47 | 2020 | |
| Endo Pharmaceuticals INC. | $12.18 | 2022 | |
| Convatec INC. | $11.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.